Invesco Ltd. Raises Stake in Maximus, Inc. $MMS

Key Points

• Invesco Ltd. increased its stake in Maximus, Inc. by 11.1% during the 1st quarter, now owning approximately 0.49% of the company, valued at $18.98 million.
• Several institutional investors expanded their positions in Maximus, with notable increases such as UMB Bank growing its stake by 70.2% and NBC Securities Inc. raising its stake by a staggering 114,900% in the same quarter.
• Maximus recently announced a quarterly dividend of $0.30 per share, representing a 1.4% dividend yield, with 97.21% of its stock held by institutional investors.

Invesco Ltd. raised its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 11.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 278,312 shares of the health services provider's stock after acquiring an additional 27,718 shares during the period. Invesco Ltd. owned approximately 0.49% of Maximus worth $18,978,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. increased its position in shares of Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after acquiring an additional 250 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after acquiring an additional 294 shares during the last quarter. NBC Securities Inc. increased its position in shares of Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after acquiring an additional 1,149 shares during the last quarter. Blue Trust Inc. increased its position in shares of Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after acquiring an additional 303 shares during the last quarter. Finally, LRI Investments LLC increased its position in shares of Maximus by 44.1% during the fourth quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock valued at $122,000 after acquiring an additional 501 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Maximus Stock Up 1.5%

Shares of NYSE MMS traded up $1.28 during midday trading on Wednesday, hitting $87.69. The company's stock had a trading volume of 1,069,588 shares, compared to its average volume of 664,742. The business's fifty day simple moving average is $75.55 and its two-hundred day simple moving average is $71.38. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.94. The firm has a market capitalization of $4.94 billion, a price-to-earnings ratio of 16.15 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm posted $1.74 earnings per share. The business's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's payout ratio is currently 22.10%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Maximus currently has an average rating of "Buy" and an average price target of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.